2023-00390: Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
The Food and Drug Administration is correcting a notice entitled "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal" that appeared in the Federal Register of December 13, 2022. The document announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →